| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.27 | 0.009 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.4 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.4 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.01 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.009 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.08 |